Polymeric sorbent, method for its production and use. – Efferon

Invention patent RU 2653125 C1. Date of registration: 23.05.2017

Polymeric sorbent, method for its production and use.

Bessonov I.V., Morozov A.S., Kopitsyna M.N.

Source

Critical Care 2024, 28(Suppl 1):P220

Hemoperfusion with Efferon LPS NEO device reverts multiple organ failure, decreases IL-6 and TNF levels and systemic immune inflammation in children with sepsis

Shock. 2023 Jun 1;59(6):846-854

Hemoperfusion using the LPS-selective mesoporous polymeric adsorbent in septic shock: a multicenter randomized clinical trial

Intensive Care Medicine Experimental 2022, 10(2): 000710

Extracorporeal hemoperfusion with Efferon LPS for rapid reconstitution of vital parameters and decreasing proinflammatory biomarkers in patients with intra-abdominal sepsis

Critical Care 2021, 25(Suppl 1): P041

Hemoperfusion with the Efferon CT extracorporeal adsorbers containing mesoporous styrene–divinylbenzene copolymer (SDC) in patients with severe COVID-19

World Journal of Medical Case Reports. Vol. 2, No. 3, 2021, pp. 46-50.

Application of novel device Efferon LPS in hemoperfusion for simultaneous removal of endotoxin and cytokines in a patient with septic shock

Therapeutic archive. 2021; 93 (7): 811-817

Extracorporeal adsorption of cytokines in cytokine release syndrome in a patient with acute lymphoblastic leukemia after therapy with T cells with a chimeric antigen receptor. Clinical observation

General resuscitation. 2020; 16 (6): 31-53.

Application of adsorbent based on a hypercrosslinked styrene-divinylbenzene copolymer with an immobilized LPS-selective ligand in hemoperfusion for the treatment of patients with septic shock

General resuscitation. 2020; 16 (4): 14-20.

Hemosorption carried out by a column filled with hypercrosslinked styrene-divinibenzene copolymer with an immobilized LPS-selective ligand in a complex of intensive treatment of acute lung injury in the surgical treatment of lung cancer (clinical observation)

General resuscitation. 2018; 14 (6): 51-60.

Efficiency and safety of a new product for LPS-selective hemosorption (experimental study)

General resuscitation. 2016; 12 (6): 82-107.

Sorbents for extracorporeal removal of toxic substances and molecules with unwanted biological activity (review)

22 July 2024

New distribution agreements in European countries

29 April 2024

Efferon LPS receives CE mark under EU MDR

20 April 2023

Results of LASSO mRCT are published in Shock